Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Oncoscience|October 2, 2015
How to target small cell lung cancerGerhard Hamilton, Barbara Rath, Ernst Ulsperger
Journal of Experimental Pharmacology|May 18, 2016
Comparison of the effects of the oral anticancer platinum(IV) complexes oxoplatin and metabolite cis-diammine-tetrachlorido-platinum(IV) on global gene expression of NCI-H526 cellsUlrike Olszewski, Ernst Ulsperger, Klaus Geissler, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 18, 2011
In vitro cytotoxicity of novel platinum-based drugs and dichloroacetate against lung carcinoid cell linesWolfgang Fiebiger, Ulrike Olszewski, Ernst Ulsperger, et al.
Oncology Reports|July 29, 2003
Effects of 1alpha,25-dihydroxy-vitamin D3 pretreatment and MAP kinase inhibitor PD 98059 on response of osteoblasts to prostate-derived osteoblastic factorsErnst Ulsperger, Gerhard Hamilton, Ulrike Olszewski, et al.
Clinical Pharmacology : Advances and Applications|February 1, 2012
In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compoundsUlrike Olszewski, Thomas Tuxen Poulsen, Ernst Ulsperger, et al.
Metal-Based Drugs|July 10, 2009
In Vitro Evaluation of Oxoplatin: An Oral Platinum(IV) Anticancer AgentUlrike Olszewski, Florian Ach, Ernst Ulsperger, et al.
Cancers|January 24, 2019
Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell LinesBarbara Rath, Lukas Klameth, Adelina Plangger, et al.
Exploration of Targeted Anti-Tumor Therapy|May 19, 2023
Small cell lung cancer: circulating tumor cell lines and expression of mediators of angiogenesis and coagulationBarbara Rath, Adelina Plangger, Lukas Klameth, et al.
Anticancer Research|August 27, 2011
Basic clinical parameters predict gefitinib efficacy in non-small cell lung cancerAndreas Pircher, Ernst Ulsperger, Rene Hack, et al.
Investigational New Drugs|August 26, 2019
Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell linesMaximilian Hochmair, Barbara Rath, Lukas Klameth, et al.
Pageof 3